medigraphic.com

2019, Número 3

<< Anterior Siguiente >>

Vet Mex 2019; 6 (3)


Anesthetic evaluation of a novel phospholipid-free 1% propofol microemulsion formulation in dogs

Aquino I, Gutiérrez-Blanco E, Ocampo L, Gutiérrez L, Bernad-Bernad MJ, Sumano H

Idioma: Español/Inglés
Referencias bibliográficas: 30
Paginas: 1-11
Archivo PDF: 132.07 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Sumano H, Pérez N, Izquierdo P, Castellanos J. Anestesia general con propofol en perros mediante infusion continua. Experiencias clinicas. Vet México. 1994;25(3):199-205.

  2. Muir W, Gadawski J. Cardiovascular effects of a high dose of romifidine in propofol- anesthetized cats. Am J Vet Res. 2002;63(9):1241-6.

  3. Selmi AL, Figueiredo JP, Mendes GM, Lavor LMS, Machado PML. Infusão contínua de propofol em gatos pré-medicados com cetamina-midazolam. Arq Bras Med Veterinária e Zootec [Internet]. 2005;57(3):295-9 [cited 2016 Nov 27]. Available from: http://www.scielo.br/scielo.php?script=sci_arttext& pid=S0102-09352005000300003&lng=en&nrm=iso&tlng=pt

  4. Sim JY, Lee SH, Park DY, Jung JA, Ki KH, Lee DH, et al. Pain on injection with microemulsion propofol. Br J Clin Pharmacol. 2009;67(3):316-25.

  5. Borwankar RP, Lobo LA, Wasan DT. Emulsion stability - kinetics of flocculation and coalescence. Colloids and Surfaces. 1992;69(2-3):135-46.

  6. Adams H. Veterinary pharmacology and therapeutics. 9th ed. Iowa: Wiley-Blackwell; 2001.

  7. Sumano H, Ocampo L. Manual de farmacología clínica para pequeñas especies. 4th ed. Mexico: Imagen Editorial Yire; 2009.

  8. Ezquerra J, Vives M. Anestesia práctica de pequeños animales. 1st ed. Madrid: McGraw Hill-Interamericana; 1992. 200 p.

  9. Marsico F, Cediel R, Gómez de Segura IA, Tendillo FJ, Criado AB. Un nuevo anestésico intravenoso: propofol : Clínica Vet pequeños Anim [Internet]. 1991;11(4):0231-9. Available from: http://ddd.uab.cat/record/69982

  10. Tsagogiorgas C, Theisinger S, Heesch E, Krebs J, Holm R, Beck G, et al. Evaluation of pharmacokinetic properties and anaesthetic effects of propofol in a new perfluorohexyloctane (F6H8) emulsion in rats. A comparative study. Int J Pharm [Internet]. 2015;486(1-2):69-76. Available from: http://dx.doi.org/10.1016/j. ijpharm.2015.03.037

  11. Thibaut J, Rivera T, Ahumada F. Anestesia endovenosa en perros mediante el uso de propofol en dosis única, premedicado con acepromazina-atropina y xilazina-atropina. Arch Med Vet [Internet]. 2002;34(1):25-35 [cited 2016 Nov 24]. Available from: http://www.scielo.cl/scielo.php?script=sci_arttext& pid=S0301-732X2002000100003&lng=en&nrm=iso&tlng=en

  12. Zorrilla-Vaca A, Escandón-Vargas K, Brand-Giraldo V, León T, Herrera M, Payán A. Bacterial contamination of propofol vials used in operating rooms of a third-level hospital. Am J Infect Control [Internet]. 2016;44(1):e1-3. Available from: http:// dx.doi.org/10.1016/j.ajic.2015.08.009

  13. Cho J, Cho JC, Lee P, Lee M, Oh E. Formulation and evaluation of an alternative triglyceride-free propofol microemulsion. Arch Pharm Res. 2010;33(9):1375-87.

  14. Dubey PK, Kumar A. Pain on injection of lipid-free propofol and propofol emulsion containing medium-chain triglyceride: A comparative study. Anesth Analg. 2005;101(4):1060-2.

  15. Nakane M, Iwama H. A potential mechanism of propofol-induced pain on injection based on studies using nafamostat mesilate. Br J Anaesth. 1999;83(3):397-404.

  16. Allchurch LG V, Crilly H. Fixed drug eruption to propofol. Anaesth Intensive Care. 2014;42(6):777-81.

  17. Graham LF, Torres SMF, Jessen CR, Horne KL, Hendrix PK. Effects of propofol-induced sedation on intradermal test reactions in dogs with atopic dermatitis. Vet Dermatol. 2003;14(3):167-76.

  18. McHale SP, Konieczko K. Anaphylactoid reaction to propofol. Anaesthesia. 1992;47(10):864-5.

  19. Li X, Zhang Y, Fan Y, Zhou Y, Wang X, Fan C, et al. Preparation and evaluation of novel mixed micelles as nanocarriers for intravenous delivery of propofol. Nanoscale Res Lett [Internet]. 2011;6(1):275. Available from: http://www. nanoscalereslett.com/content/6/1/275

  20. Wallentine CB, Shimode N, Egan TD, Pace NL. Propofol in a modified cyclodextrin formulation: First human study of dose-response with emphasis on injection pain. Anesth Analg. 2011;113(4):738-41.

  21. Lang BC, Yang J, Wang Y, Luo Y, Kang Y, Liu J, et al. An improved design of water-soluble propofol prodrugs characterized by rapid onset of action. Anesth Analg. 2014;118(4):745-54.

  22. Minghella E, Benmansour P, Iff I, Senior JM, Mosing M. Pain after injection of a new formulation of propofol in six dogs. Vet Rec [Internet]. 2010;167(22):866- 7. Available from: http://veterinaryrecord.bmj.com/cgi/doi/10.1136/vr.c5736

  23. SAGARPA. Especificaciones técnicas para la producción, cuidado y uso de los animales de laboratorio. [Internet]. Diario oficial de la federación. México; 1999. p. 57. Available from: http://www.senasica.gob.mx/?doc=743

  24. Bayne KAL. Environmental Enrichment of Nonhuman Primates, Dogs and Rabbits Used in Toxicology Studies. Toxicol Pathol. 2004;31(1 Suppl):132-7.

  25. Sumano H, Ocampo L. Farmacología veterinaria. 4th ed. México: Aranda; 2016.

  26. World Health Organization. Stability testing of active pharmaceutical ingredients and finished pharmaceutical products, Annex 10. WHO Expert Comm Specif Pharm Prep. 2018;(52):309-51.

  27. Martinez-Taboada F, Leece EA. Comparison of propofol with ketofol, a propofol- ketamine admixture, for induction of anaesthesia in healthy dogs. Vet Anaesth Analg [Internet]. 2014;41(6):575-82. Available form: http://dx.doi. org/10.1111/vaa.12171

  28. Bigby SE, Beths T, Bauquier S, Carter JE. Postinduction apnoea in dogs premedicated with acepromazine or dexmedetomidine and anaesthetized with alfaxalone or propofol. Vet Anaesth Analg. 2017;44(5):1007-15.

  29. Bjur KA, Cannon BC, Fine AL, Ritter MJ, Schueler KE, Nemergut ME. Propylene Glycol Toxicity in Adolescent with Refractory Myoclonic Status Epilepticus. Case Rep Pediatr [Internet]. 2017;2017:1-3. Available from: https://www.hindawi. com/journals/cripe/2017/2979486/

  30. Nanopolytox. Toxicological impact of nanomaterials derived from processing, weathering and recycling of polymer nanocomposites used in various industrial applications [Internet]. España; 2016. Available from: https://cordis.europa.eu/ project/rcn/94382/brief/es




2020     |     www.medigraphic.com